Growing investments in biotechnology and pharmaceutical research and development, along with government funding, are driving market growth.
Aptamers are in high demand for detecting contaminants, toxins, and pathogens in food and environmental monitoring.
Aptamers are being used extensively in point-of-care testing and biosensors for rapid disease detection, particularly in Covid-19 and other infectious diseases.
Key players in the aptamers market include Aptamer Group, Raptamer Discovery Group, SomaLogic Inc., and Aptamer Sciences, Inc.